News in brief

27 Mar 1998

* Lehman Brothers has completed one of the most successful French IPOs this year with the sale of stock in bio-tech group Transgene. The offering, which was around 15 times oversubscribed, results in a dual listing for the company on the Nouveau Marché and Nasdaq. Lehman and ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.